NEU 1.99% $13.79 neuren pharmaceuticals limited

patient enrolment begins april 2010, page-17

  1. 16,450 Posts.
    lightbulb Created with Sketch. 772
    Two phase II trials for large unmet needs ,traumatic brain injury announced today and post stroke apathy announced in march.

    Find me another biotech company that has two fully funded phase two trials and only has a market value less than $12m.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.79
Change
-0.280(1.99%)
Mkt cap ! $1.762B
Open High Low Value Volume
$13.73 $13.88 $13.40 $9.796M 714.7K

Buyers (Bids)

No. Vol. Price($)
1 1588 $13.78
 

Sellers (Offers)

Price($) Vol. No.
$13.84 1625 2
View Market Depth
Last trade - 16.10pm 04/09/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.